SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-020525
Filing Date
2018-04-13
Accepted
2018-04-13 16:40:30
Documents
8
Period of Report
2018-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv491021_8k.htm 8-K 27950
2 EXHIBIT 1.1 tv491021_ex1-1.htm EX-1.1 185380
3 EXHIBIT 5.1 tv491021_ex5-1.htm EX-5.1 7109
4 EXHIBIT 99.1 tv491021_ex99-1.htm EX-99.1 10057
5 EXHIBIT 99.2 tv491021_ex99-2.htm EX-99.2 10515
6 GRAPHIC tv491021_ex99-1img1.jpg GRAPHIC 14007
7 GRAPHIC tv491021_ex99-2img2.jpg GRAPHIC 14007
8 GRAPHIC tv491021_ex5-1img3.jpg GRAPHIC 6740
  Complete submission text file 0001144204-18-020525.txt   290464
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 18754768
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1